194 related articles for article (PubMed ID: 15447989)
1. Identification of a novel human cancer/testis antigen, KM-HN-1, recognized by cellular and humoral immune responses.
Monji M; Nakatsura T; Senju S; Yoshitake Y; Sawatsubashi M; Shinohara M; Kageshita T; Ono T; Inokuchi A; Nishimura Y
Clin Cancer Res; 2004 Sep; 10(18 Pt 1):6047-57. PubMed ID: 15447989
[TBL] [Abstract][Full Text] [Related]
2. Identification of HLA-A24-restricted CTL epitope from cancer-testis antigen, NY-ESO-1, and induction of a specific antitumor immune response.
Yamaguchi H; Tanaka F; Ohta M; Inoue H; Mori M
Clin Cancer Res; 2004 Feb; 10(3):890-6. PubMed ID: 14871964
[TBL] [Abstract][Full Text] [Related]
3. Identification of a novel cancer-testis antigen CRT2 frequently expressed in various cancers using representational differential analysis.
Hayashi E; Matsuzaki Y; Hasegawa G; Yaguchi T; Kurihara S; Fujita T; Kageshita T; Sano M; Kawakami Y
Clin Cancer Res; 2007 Nov; 13(21):6267-74. PubMed ID: 17975137
[TBL] [Abstract][Full Text] [Related]
4. Ran, a small GTPase gene, encodes cytotoxic T lymphocyte (CTL) epitopes capable of inducing HLA-A33-restricted and tumor-reactive CTLs in cancer patients.
Azuma K; Sasada T; Takedatsu H; Shomura H; Koga M; Maeda Y; Yao A; Hirai T; Takabayashi A; Shichijo S; Itoh K
Clin Cancer Res; 2004 Oct; 10(19):6695-702. PubMed ID: 15475460
[TBL] [Abstract][Full Text] [Related]
5. Proliferation potential-related protein, an ideal esophageal cancer antigen for immunotherapy, identified using complementary DNA microarray analysis.
Yoshitake Y; Nakatsura T; Monji M; Senju S; Matsuyoshi H; Tsukamoto H; Hosaka S; Komori H; Fukuma D; Ikuta Y; Katagiri T; Furukawa Y; Ito H; Shinohara M; Nakamura Y; Nishimura Y
Clin Cancer Res; 2004 Oct; 10(19):6437-48. PubMed ID: 15475430
[TBL] [Abstract][Full Text] [Related]
6. Identification of a gene coding for a protein possessing shared tumor epitopes capable of inducing HLA-A24-restricted cytotoxic T lymphocytes in cancer patients.
Yang D; Nakao M; Shichijo S; Sasatomi T; Takasu H; Matsumoto H; Mori K; Hayashi A; Yamana H; Shirouzu K; Itoh K
Cancer Res; 1999 Aug; 59(16):4056-63. PubMed ID: 10463607
[TBL] [Abstract][Full Text] [Related]
7. Inducible Hsp70 as target of anticancer immunotherapy: Identification of HLA-A*0201-restricted epitopes.
Faure O; Graff-Dubois S; Bretaudeau L; Derré L; Gross DA; Alves PM; Cornet S; Duffour MT; Chouaib S; Miconnet I; Grégoire M; Jotereau F; Lemonnier FA; Abastado JP; Kosmatopoulos K
Int J Cancer; 2004 Mar; 108(6):863-70. PubMed ID: 14712489
[TBL] [Abstract][Full Text] [Related]
8. Detection of a set of peptide vaccine candidates for use in HLA-A31+ epithelial cancer patients.
Takedatsu H; Shichijo S; Azuma K; Takedatsu H; Sata M; Itoh K
Int J Oncol; 2004 Feb; 24(2):337-47. PubMed ID: 14719110
[TBL] [Abstract][Full Text] [Related]
9. Spontaneous tumor-specific humoral and cellular immune responses to NY-ESO-1 in hepatocellular carcinoma.
Korangy F; Ormandy LA; Bleck JS; Klempnauer J; Wilkens L; Manns MP; Greten TF
Clin Cancer Res; 2004 Jul; 10(13):4332-41. PubMed ID: 15240519
[TBL] [Abstract][Full Text] [Related]
10. Novel human testis-specific cDNA: molecular cloning, expression and immunobiological effects of the recombinant protein.
Santhanam R; Naz RK
Mol Reprod Dev; 2001 Sep; 60(1):1-12. PubMed ID: 11550262
[TBL] [Abstract][Full Text] [Related]
11. XAGE-1 expression in non-small cell lung cancer and antibody response in patients.
Nakagawa K; Noguchi Y; Uenaka A; Sato S; Okumura H; Tanaka M; Shimono M; Ali Eldib AM; Ono T; Ohara N; Yoshino T; Yamashita K; Tsunoda T; Aoe M; Shimizu N; Nakayama E
Clin Cancer Res; 2005 Aug; 11(15):5496-503. PubMed ID: 16061866
[TBL] [Abstract][Full Text] [Related]
12. A new tumor-rejection antigen recognized by cytotoxic T lymphocytes infiltrating into a lung adenocarcinoma.
Nishizaka S; Gomi S; Harada K; Oizumi K; Itoh K; Shichijo S
Cancer Res; 2000 Sep; 60(17):4830-7. PubMed ID: 10987294
[TBL] [Abstract][Full Text] [Related]
13. An HLA-A24-restricted cytotoxic T lymphocyte epitope of a tumor-associated protein, survivin.
Hirohashi Y; Torigoe T; Maeda A; Nabeta Y; Kamiguchi K; Sato T; Yoda J; Ikeda H; Hirata K; Yamanaka N; Sato N
Clin Cancer Res; 2002 Jun; 8(6):1731-9. PubMed ID: 12060610
[TBL] [Abstract][Full Text] [Related]
14. The centrosomal localization of KM-HN-1 (MGC33607) depends on the leucine zipper motif and the C-terminal coiled-coil domain.
Park HJ; Seo HJ; Kim HW; Kim JS; Hwang SY; Seong YS
Exp Mol Med; 2007 Dec; 39(6):828-38. PubMed ID: 18160854
[TBL] [Abstract][Full Text] [Related]
15. Aberrant expression and potency as a cancer immunotherapy target of inhibitor of apoptosis protein family, Livin/ML-IAP in lung cancer.
Hariu H; Hirohashi Y; Torigoe T; Asanuma H; Hariu M; Tamura Y; Aketa K; Nabeta C; Nakanishi K; Kamiguchi K; Mano Y; Kitamura H; Kobayashi J; Tsukahara T; Shijubo N; Sato N
Clin Cancer Res; 2005 Feb; 11(3):1000-9. PubMed ID: 15709165
[TBL] [Abstract][Full Text] [Related]
16. Identification of squamous cell carcinoma antigen-derived peptides having the capacity of inducing cancer-reactive CTLs in HLA-A24+ cancer patients.
Homma S; Harada M; Yano H; Ogasawara S; Shichijo S; Matsueda S; Komatsu N; Shomura H; Maeda Y; Sato Y; Todo S; Itoh K
Int J Oncol; 2006 Sep; 29(3):577-87. PubMed ID: 16865273
[TBL] [Abstract][Full Text] [Related]
17. Prostate-specific antigen-derived epitopes capable of inducing cellular and humoral responses in HLA-A24+ prostate cancer patients.
Harada M; Kobayashi K; Matsueda S; Nakagawa M; Noguchi M; Itoh K
Prostate; 2003 Oct; 57(2):152-9. PubMed ID: 12949939
[TBL] [Abstract][Full Text] [Related]
18. Multiple antigenic peptides of human heparanase elicit a much more potent immune response against tumors.
Wang GZ; Tang XD; Lü MH; Gao JH; Liang GP; Li N; Li CZ; Wu YY; Chen L; Cao YL; Fang DC; Yang SM
Cancer Prev Res (Phila); 2011 Aug; 4(8):1285-95. PubMed ID: 21505182
[TBL] [Abstract][Full Text] [Related]
19. Identification of antigenic epitopes recognized by Mac-2 binding protein-specific cytotoxic T lymphocytes in an HLA-A24 restricted manner.
Kontani K; Teramoto K; Ozaki Y; Fujita T; Tezuka N; Sawai S; Watanabe H; Fujino S; Yokomise H; Ohkubo I
Int J Oncol; 2004 Dec; 25(6):1537-42. PubMed ID: 15547688
[TBL] [Abstract][Full Text] [Related]
20. CTp11, a novel member of the family of human cancer/testis antigens.
Zendman AJ; Cornelissen IM; Weidle UH; Ruiter DJ; van Muijen GN
Cancer Res; 1999 Dec; 59(24):6223-9. PubMed ID: 10626816
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
